TrialsgrambetaRCTs are beautiful

Cystic & hereditary kidney disease

Vasopressin antagonism in ADPKD and hereditary nephropathies.

  • 2020EARLY-PRO-TECT⁠Alport syndromeIn 80 children with Alport syndrome, early ramipril delayed progression of albuminuria compared with placebo.HR 0.5195% CI 0.12-2.20Read →
  • 2017REPRISE⁠ADPKDIn 1,370 patients with later-stage ADPKD, tolvaptan slowed eGFR decline compared with placebo.Read →
  • 2012TEMPO 3:4⁠ADPKDIn 1,445 patients with autosomal dominant polycystic kidney disease, tolvaptan slowed total kidney-volume growth compared with placebo.Read →